Welcome to our dedicated page for Ainos news (Ticker: AIMD), a resource for investors and traders seeking the latest updates and insights on Ainos stock.
Ainos, Inc. reports developments tied to its transition toward AI-powered scent intelligence and industrial sensing. The company centers its commercial focus on AI Nose, an electronic olfaction platform that uses sensor arrays and proprietary artificial intelligence models, including its Smell Language Model, to convert volatile organic compound and scent signals into machine-readable Smell ID data.
Recurring news themes include AI Nose commercialization across semiconductor manufacturing, robotics, smart infrastructure, and healthcare-related environments; distribution and deployment relationships; industry classification updates; and financial results connected to the platform. Ainos also maintains a therapeutic-development program around VELDONA, a low-dose oral interferon program targeting rare, autoimmune, and infectious diseases.
Ainos (NASDAQ:AIMD) began live AI Nose deployments in semiconductor manufacturing after receiving an initial $2.1 million order from a back-end packaging and testing customer. Preparations in the second half of 2025 enabled on-site rollouts that started in January 2026.
Back-end deployments are now operating in live environments generating scent data, while front-end semiconductor pilots advance to broaden use cases and strengthen Ainos' Smell Language Model (SLM).
Ainos (NASDAQ:AIMD) announced a strategic partnership with Mirle to integrate its AI Nose SmellTech into Mirle's mobile and quadruped robotic platforms, extending deployments from commercial buildings into industrial environments such as semiconductor fabs and advanced manufacturing.
The collaboration aims to add chemical sensing to vision and audio, improve early detection of gas leaks and VOCs, and accelerate real-world data collection to scale the Smell ID library and platform capabilities.
Ainos (NASDAQ:AIMD) is advancing its AI Nose SmellTech platform, positioning scent as a native AI data layer through standardized Smell IDs and a proprietary Smell Language Model. The company reported multi-year semiconductor back-end orders of approximately $2.1M for ~1,400 AI Nose units and highlighted robotics partnerships to scale continuous scent data generation in 2026.
The firm's dual-engine architecture separates physical sensing from intelligence-as-a-service (via subsidiary ScentAI) to pursue recurring subscription economics, broader industrial deployments across front-end and back-end semiconductor operations, and accelerated data flywheel growth via robotics partnerships.
Ainos (NASDAQ:AIMD) announced a technology partnership with Mirle Automation on February 2, 2026, to integrate Ainos' AI Nose scent‑digitizing platform into mobile and quadruped robotic platforms.
The collaboration targets inspection, monitoring, and autonomous tasks — detecting VOCs, gas leaks, and chemical anomalies — to boost robotic situational awareness and safety across fabs, manufacturing, healthcare, outdoor inspection, and security applications.
Ainos (NASDAQ:AIMD / AIMDW) will participate in a fireside chat with Water Tower Research on Monday, January 26, 2026 at 11:00 a.m. ET.
The company will discuss its dual-engine SmellTech platform, partnership with Trusval Technology, progress scaling AI Nose technology toward commercial deployment, and strategic priorities for 2026. The event is listen-only and a replay will be posted under "Events" on Ainos' investor relations site.
Ainos (NASDAQ:AIMD) is advancing AI Nose from R&D toward scaled commercial deployment in 2026, supported by a dual-engine architecture separating hardware sensing and a software ScentAI layer. A three-year distribution and deployment agreement with Trusval Technology includes an initial minimum commitment of 600 AI Nose units, targeting front-end semiconductor wafer fabrication and broader manufacturing use cases. The structure aims to enable recurring, SaaS-style revenue through APIs, licensing, and subscriptions while expanded deployments feed a growing Smell ID library and machine-learning performance. Ainos relocated its U.S. headquarters to Houston, Texas in early 2026 to align with industrial and semiconductor ecosystems.
Ainos (NASDAQ:AIMD) announced a distribution and deployment agreement with Taiwan-based Trusval Technology on January 7, 2026 to expand AI Nose into semiconductor front-end manufacturing.
Under the contract, Trusval will be Ainos' authorized sales agent and deployment partner for front-end wafer fab applications, with an initial minimum purchase commitment of 600 AI Nose units to support real-world deployments and scent data accumulation in high-precision manufacturing environments.
The deal extends Ainos' SmellTech footprint upstream from back-end processes and aligns with the company's 2026 execution focus on disciplined, contract‑driven platform expansion.
Ainos (NASDAQ:AIMD) outlined a long-term platform strategy to digitize smell as a native AI data language and described a dual-engine SmellTech architecture split between hardware sensing and AI intelligence.
Ainos will own design, manufacturing, deployment, and data generation for its AI Nose sensors while wholly owned ScentAI will develop the Smell Language Model (SLM) to classify, contextualize, and scale scent data via APIs, SaaS, and model licensing. 2026 priorities target scaled deployments in advanced semiconductor manufacturing and robotics to accelerate data accumulation and SLM training.
Ainos (NASDAQ:AIMD / AIMDW) will relocate its U.S. headquarters to Houston, Texas in early 2026 and has formed a wholly owned software subsidiary, ScentAI Inc.
ScentAI will develop a smell language model (SLM) that converts scent signals into Smell ID tokens and will be co-located with Ainos' HQ to integrate AI Nose hardware data with model development. Management described the move as improving operating efficiency and enabling U.S. commercialization after recent deployments in Asia.
Ainos (NASDAQ:AIMD) reported third-quarter 2025 developments as it accelerates commercial scale-up of its AI Nose scent‑digitization platform ahead of 2026. Key operational moves include expanding industrial partnerships to six, a distribution agreement with Topco across the U.S., Taiwan, Japan and Southeast Asia, a strategic partnership with NEXCOM (Oct 14, 2025), and reclassification under GICS to Technology Hardware, Storage & Peripherals effective Oct 1, 2025. The company launched its first commercial portable AI Nose (Aug 14, 2025) and added seven patents on Sep 30, 2025, bringing the total to 123 active patents. Management cited cost discipline with S,G&A down 22% YoY and total operating expenses down 8%.